SGOL | USL | SGOL / USL | |
Gain YTD | 25.469 | -12.852 | -198% |
Net Assets | 5.03B | 38M | 13,224% |
Total Expense Ratio | 0.17 | 1.02 | 17% |
Turnover | N/A | N/A | - |
Yield | 0.00 | 0.00 | - |
Fund Existence | 16 years | 18 years | - |
SGOL | USL | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 4 days ago77% | 4 days ago90% |
Momentum ODDS (%) | 4 days ago87% | 4 days ago77% |
MACD ODDS (%) | 4 days ago65% | 4 days ago90% |
TrendWeek ODDS (%) | 4 days ago84% | 4 days ago82% |
TrendMonth ODDS (%) | 4 days ago73% | 4 days ago86% |
Advances ODDS (%) | 13 days ago81% | 14 days ago89% |
Declines ODDS (%) | 6 days ago69% | 4 days ago82% |
BollingerBands ODDS (%) | N/A | 4 days ago89% |
Aroon ODDS (%) | 4 days ago63% | 4 days ago88% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBDW | 20.78 | 0.07 | +0.34% |
iShares iBonds Dec 2031 Term Corp ETF | |||
XSVN | 47.32 | 0.13 | +0.28% |
BondBloxx Bloomberg SevenYrTrgDurUSTrETF | |||
NUMV | 34.93 | N/A | N/A |
Nuveen ESG Mid-Cap Value ETF | |||
XTR | 26.81 | N/A | N/A |
Global X S&P 500® Tail Risk ETF | |||
BIB | 43.02 | -1.93 | -4.29% |
ProShares Ultra Nasdaq Biotechnology |